Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Effexor;Effexor XR;Efexor

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

86 API Suppliers, 42 USDMF, 47 CEP/COS, 3 JDMF, 24 EU WC, 6 KDMF, 19 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

412 FDF Dossiers, 183 FDA Orange Book, 153 Europe, 46 Canada, 7 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 13 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 12 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 39 BASF, 2 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 46 Controlled & Modified Release, 44 Direct Compression, 42 Thickeners and Stabilizers, 39 Solubilizers, 38 Granulation, 33 Taste Masking, 30 Topical, 26 Film Formers & Plasticizers, 24 Lubricants & Glidants, 23 Parenteral, 21 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 12 Emulsifying Agents, 10 Surfactant & Foaming Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 32 Regulatory FDF Prices

MARKET PLACE

12 APIs, 1 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Cohance Lifesciences	India	COHANCE LIFESCIENCES LIMITED Hyderabad IN	R1-CEP 2016-074 - Rev 01	Venlafaxine hydrochloride	2022-12-16	Valid	Chemical		2119
29/11/2025	Moehs Iberica	Spain	Moehs Iberica S.L. Rubi ES	R1-CEP 2006-182 - Rev 04	Venlafaxine hydrochloride, Standard and milled	2020-02-04	Valid	Chemical		2119

Effexor;Effexor XR;Efexor

Effexor;Effexor XR;Efexor

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

86 API Suppliers

42 USDMF

47 CEP/COS

3 JDMF

24 EU WC

6 KDMF

19 NDC API

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

412 FDF Dossiers

183 FDA Orange Book

153 Europe

46 Canada

7 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem

13 Evonik

2 Rochem International Inc

20 SPI Pharma

12 DKSH

1 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

39 BASF

2 CD Formulation

2 Clariant

16 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

9 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

25 Roquette

17 Seppic